Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Timothy Jancel"'
Autor:
Cecilia B. Korol, Shamira J. Shallom, Kriti Arora, Helena I. Boshoff, Alexandra F. Freeman, Alejandra King, Sonia Agrawal, Sean C. Daugherty, Timothy Jancel, Juraj Kabat, Sundar Ganesan, Marina N. Torrero, Elizabeth P. Sampaio, Clifton Barry, Steve M Holland, Hervé Tettelin, Sergio D Rosenzweig, Adrian M. Zelazny
Publikováno v:
Virulence, Vol 11, Iss 1, Pp 1656-1673 (2020)
Summary: We characterized Mycobacterium bovis BCG isolates found in lung and brain samples from a previously vaccinated patient with IFNγR1 deficiency. The isolates collected displayed distinct genomic and phenotypic features consistent with host ad
Externí odkaz:
https://doaj.org/article/c389e6b7ad754220ad0f5defb0a60810
Autor:
Adrian M. Zelazny, Kriti Arora, Elizabeth P. Sampaio, Timothy Jancel, Cecilia B. Korol, Alexandra F. Freeman, Shamira J. Shallom, Sean C. Daugherty, Marina N. Torrero, Sergio D. Rosenzweig, Hervé Tettelin, Sundar Ganesan, Sonia Agrawal, Clifton E. Barry, Alejandra King, Helena I. Boshoff, Steve M. Holland, Juraj Kabat
Publikováno v:
Virulence
article-version (VoR) Version of Record
Virulence, Vol 11, Iss 1, Pp 1656-1673 (2020)
article-version (VoR) Version of Record
Virulence, Vol 11, Iss 1, Pp 1656-1673 (2020)
Summary: We characterized Mycobacterium bovis BCG isolates found in lung and brain samples from a previously vaccinated patient with IFNγR1 deficiency. The isolates collected displayed distinct genomic and phenotypic features consistent with host ad
Autor:
Timothy Jancel, Tiffany Kim, Scott R. Penzak, Steven M. Holland, Claire W. Hallahan, Pamela A. Shaw, Alexandra F. Freeman
WHAT IS KNOWN AND OBJECTIVE Posaconazole is an extended-spectrum triazole antifungal with activity against a variety of clinically significant yeasts and moulds. Posaconazole is not currently approved by the U.S. Food and Drug Administration for use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff278215464ecfb8c23571c94c99f47b
https://europepmc.org/articles/PMC5209268/
https://europepmc.org/articles/PMC5209268/
Autor:
Amber N. Shatzer, Gulbu Uzel, Stefania Pittaluga, Rebecca A. Marsh, Feng-Yen Li, Jack J. Bleesing, Jeffrey I. Cohen, Ping Jiang, Timothy Jancel, Geraldine M. O’Connor, Helen F. Matthews, Huseyin Mehmet, Michael J. Lenardo, Taco W. Kuijpers, Matthew Biancalana, Kim E. Nichols, Benjamin Chaigne-Delalande, Sunil Nagpal, Marshall J. Lukacs, Lixin Zheng, Helen C. Su, Carrie L. Lucas
Publikováno v:
Science, 341(6142), 186-191. American Association for the Advancement of Science
Magnesium to the Rescue Individuals with X-linked immunodeficiency with Mg 2+ defect, Epstein-Barr virus (EBV) infection, and neoplasia (XMEN) disease are genetically deficient for expression of MAGT1 , a magnesium transporter. Chaigne-Delalande et a
Autor:
Alexandra F. Freeman, Hannelore I. Bax, Reginald J. Claypool, Kenneth N. Olivier, Timothy Jancel, Li Ding, Christa S. Zerbe, Joseph Pechacek, Lisa A. Barnhart, B.E. Marciano, Amy P. Hsu, Christine Spalding, Elizabeth P. Sampaio, Ervand Kristosturyan, Cathleen Frein, Victoria L. Anderson, Lisa Boris, S.M. Holland
Publikováno v:
Journal of Clinical Immunology, 33(5), 991-1001. Springer New York
Patients with deficiency in the interferon gamma receptor (IFN-gamma R) are unable to respond properly to IFN-gamma and develop severe infections with nontuberculous mycobacteria (NTM). IFN-gamma and IFN-alpha are known to signal through STAT1 and ac
Autor:
Vicky Dudas, Timothy Jancel
Publikováno v:
Western Journal of Medicine. 176:51-55
Uncomplicated urinary tract infections are among the most frequently occurring infections in the United States, resulting in an estimated 8 million office visits and 1 million hospital admissions each year.1,2,3 Between 40% and 50% of women have repo
Autor:
Eleanor Wilson, Edward W. Cowen, Yvonne R. Shea, Timothy Jancel, Maria L. Turner, Peggy A. Wu, Alexandra F. Freeman
Publikováno v:
Journal of the American Academy of Dermatology. 63(6)
Autor:
Timothy Jancel, Scott R. Penzak
Publikováno v:
Seminars in hematology. 46(3)
Advances in supportive care over the past two decades have decreased the morbidity and mortality attributed to opportunistic infections in immunocompromised patients, including those with hematologic malignancies, hematopoietic stem cell transplantat
Publikováno v:
Clinical Infectious Diseases. 50:939-940